TPG-backed drugmaker Aptalis files for IPO of up to $500 million

(Reuters) - Specialty drugmaker Aptalis Holdings Inc, owned by private equity firm TPG Capital LP, filed with U.S. regulators to raise up to $500 million in an initial public offering of its common...

from Reuters: Deals http://feeds.reuters.com/~r/news/deals/~3/yhZ-LaNNXaY/us-aptalis-ipo-idUSBRE9BP09520131226